- Report
- January 2023
- 308 Pages
Global
From €4879EUR$5,292USD£3,950GBP
- Report
- May 2022
- 111 Pages
Global
€4533EUR$4,750USD£3,798GBP
- Report
- November 2024
- 95 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- November 2024
- 84 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- November 2023
- 107 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- April 2022
- 93 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- November 2024
- 99 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- December 2023
- 94 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- June 2022
- 86 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 146 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- October 2023
- 146 Pages
Global
From €3367EUR$3,528USD£2,821GBP
€3961EUR$4,150USD£3,318GBP
- Report
- September 2023
- 35 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €3813EUR$3,995USD£3,195GBP
- Report
- August 2023
- 17 Pages
United States
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
United Kingdom
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
Spain
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
South Korea
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
Russia
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
Mexico
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
Japan
From €2858EUR$2,995USD£2,395GBP
- Report
- August 2023
- 17 Pages
Italy
From €2858EUR$2,995USD£2,395GBP

The Deep Brain Stimulator (DBS) market is a subset of the larger Neurology Devices market. It is a rapidly growing field, with DBS devices being used to treat a variety of neurological disorders, including Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. DBS works by delivering electrical stimulation to specific areas of the brain, which can help reduce symptoms and improve quality of life. The technology is also being explored for use in treating depression, addiction, and other mental health conditions.
The DBS market is highly competitive, with a number of companies offering a range of devices and services. These include Medtronic, Abbott, Boston Scientific, St. Jude Medical, and NeuroPace. Additionally, there are a number of smaller companies that specialize in DBS technology, such as NeuroSigma, NeuroPace, and NeuroSurg. Show Less Read more